Acceleration of the development of diabetes in obese diabetic (db/bd) miceby nicotinamide: A comparison with its antidiabetic effects in non-obese diabetic mice
V. Piercy et al., Acceleration of the development of diabetes in obese diabetic (db/bd) miceby nicotinamide: A comparison with its antidiabetic effects in non-obese diabetic mice, METABOLISM, 49(12), 2000, pp. 1548-1554
Destruction of pancreatic beta cells has been implicted in the progression
to hyperglycemia in type 1 diabetes. While there is evidence of beta -cell
loss in type 2 diabetes, its contribution to the development of the diabeti
c state is undecided. Nicotinamide has defensive effects against toxic insu
lts to the pancreatic islets and confers protection in both human and anima
l models of type 1 diabetes, but its effects on type 2 diabetes are less we
ll documented. This report describes a comparison of the outcome of chronic
oral administration of nicotinamide on the development of diabetes in obes
e diabetic (db/db) and non-obese diabetic (NOD) mice models of type 2 and t
ype 1 diabetes, respectively. Nicotinamide was administered in the diet (5
g/kg diet) for 12 (db/db) or 24 (NOD) weeks. Over the 1:2 weeks of the stud
y, control diabetic (db/db) mice became progressively more hyperglycemic an
d glycosuric, while serum and pancreatic insulin levels decreased compared
with those on day 0. In mice treated with nicotinamide, there was a pronoun
ced acceleration in the development of hyperglycemia and glycosuria, as wel
l as a decrease in pancreatic insulin levels, compared with time-matched co
ntrols. In addition, the morphology of the pancreatic islets of nicotinamid
e-treated diabetic (db/db) mice showed an enhanced islet disorganization. B
y comparison, in NOD mice, nicotinamide prevented the decline in serum and
pancreatic insulin levels and maintained normal islet architecture and insu
lin content. Our data shows that in contrast to its preventative effects on
the development of autoimmune diabetes in NOD mice, chronic nicotinamide a
dministration to obese diabetic (db/db) mice markedly accelerated the progr
ession of diabetes. The results of our study caution against the use of nic
otinamide in insulin-resistant states, such as type 2 diabetes. Copyright (
C) 2000 by W.B. Saunders Company.